Literature DB >> 9052578

Effect of bone density information on decisions about hormone replacement therapy: a randomized trial.

S L Silverman1, M Greenwald, R A Klein, B L Drinkwater.   

Abstract

OBJECTIVE: To determine the effect of bone density information on a woman's decision about hormone replacement therapy (HRT).
METHODS: One hundred forty women were assigned randomly to receive either educational information about osteoporosis and a voucher for a bone mineral density test 12 months later or the same educational information plus an immediate dual-energy x-ray absorptiometry test for bone mineral density. Women in both groups were offered prescription for HRT.
RESULTS: Of the 93 women who received a bone mineral density test, 63.4% elected HRT and filled their prescription, compared with only 20.0% of the 43 women who did not have a bone mineral density test (P < .01). Women who were classified as osteopenic (between -1 and -2.5 standard deviations [SDs] of the young normal bone mineral density) or osteoporotic (more than 2.5 SDs below young normals) were more likely to choose HRT (69.4%) than were women whose bone mineral density was in the normal range (51.6%) (above -1 SD of the young normal bone mineral density value).
CONCLUSIONS: A bone mineral density test, regardless of the result, had a significant effect on women's decisions to accept HRT. Within the group having the test, women with lower bone mineral density were more likely to choose HRT.

Entities:  

Mesh:

Year:  1997        PMID: 9052578     DOI: 10.1016/S0029-7844(97)85857-7

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  18 in total

1.  Influence of bone densitometry results on the treatment of osteoporosis.

Authors:  N S Fitt; S L Mitchell; A Cranney; K Gulenchyn; M Huang; P Tugwell
Journal:  CMAJ       Date:  2001-03-20       Impact factor: 8.262

2.  Impact of bone turnover markers and/or educational information on persistence to oral bisphosphonate therapy: a community setting-based trial.

Authors:  S L Silverman; K Nasser; S Nattrass; B Drinkwater
Journal:  Osteoporos Int       Date:  2011-07-14       Impact factor: 4.507

3.  Medical treatment of osteoporotic vertebral fractures.

Authors:  Bente Lomholt Langdahl; Torben Harsløf
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-02       Impact factor: 5.346

4.  Limited utility of clinical indices for the prediction of symptomatic fracture risk in postmenopausal women.

Authors:  Tuan V Nguyen; Jacqueline R Center; Nicholas A Pocock; John A Eisman
Journal:  Osteoporos Int       Date:  2003-10-30       Impact factor: 4.507

5.  Factors related to the use of bone densitometry: survey responses of 494 primary care physicians in New England.

Authors:  D H Solomon; M T Connelly; C J Rosen; B Dawson-Hughes; D P Kiel; S L Greenspan; E S Leib; M Holick; A H Miguel; J S Finkelstein
Journal:  Osteoporos Int       Date:  2003-03-14       Impact factor: 4.507

Review 6.  Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA).

Authors:  Nelson B Watts
Journal:  Osteoporos Int       Date:  2004-08-21       Impact factor: 4.507

7.  How are family physicians managing osteoporosis? Qualitative study of their experiences and educational needs.

Authors:  Susan B Jaglal; June Carroll; Gillian Hawker; Warren J McIsaac; Liisa Jaakkimainen; Suzanne M Cadarette; Cathy Cameron; Dave Davis
Journal:  Can Fam Physician       Date:  2003-04       Impact factor: 3.275

Review 8.  Adherence with medications used to treat osteoporosis: behavioral insights.

Authors:  John T Schousboe
Journal:  Curr Osteoporos Rep       Date:  2013-03       Impact factor: 5.096

9.  Access to bone densitometry increases general practitioners' prescribing for osteoporosis in steroid treated patients.

Authors:  A L Dolan; E Koshy; M Waker; C M Goble
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

Review 10.  Clinical decision support tools for osteoporosis disease management: a systematic review of randomized controlled trials.

Authors:  Monika Kastner; Sharon E Straus
Journal:  J Gen Intern Med       Date:  2008-10-04       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.